Article Text
PDF
Statistics from Altmetric.com
Aalbers CJ et al. Improvement of rAAV5 transduction efficiency in fibroblast-like synoviocytes by doxorubicin, A46
Abbate R A87
Abreu JRF A40
Abreu JRF et al. Maintenance of T cell Rap1 signalling protects mice against collagen-induced arthritis, A66
af Klint E A58
Água-Doce AM A166
Åhlin E A15
Åhlin E et al. SSA and SSB antibodies are important in the formation of circulating immune complexes in SLE, A6
Airò P A22
Aksentijevich I A72
Alard J-E A105
Al-Edreese M A15
Aleixo I A51
Alemayehu WG A18
Alemo-Munters L A158
Alexander T et al. Identification of cellular markers predicting relapses after immunoablation and autologous haematopoietic stem cell transplantation (ASCT) for refractory systemic lupus erythematosus, A52
Alissafi T A136
Allanore Y A162
Amaral PM A51
Ambarus C A103
Ambarus CA A33
Anaja J-M A20
Andersone D A100
Antal P A181
Antoniou M A144
Arajs J A100
Arnold R A132
Arntz OJ et al. Chondrocytes from arthritic cartilage in a subset of osteoarthritis patients express lower levels of nfκB-p65: a survival factor against tumour necrosis factor α-induced cell death, A18
Asnagli H A179
Asquith DL A101
Asquith DL et al. Apoe-deficient mice are resistant to the development of collagen-induced arthritis, A54
Assier E et al. IL-23 specific targeting by active immunisation improves inflammation and destruction in a murine model of rheumatoid arthritis, A46, VEGF targeting by active immunisation improves joint inflammation and destruction in a murine model of rheumatoid arthritis, A46
Astica I A100
Astorri E A31
Audo R et al. Regulation of pleitropic effect of TRAIL on RAFLS by TRAIL-R1 and -R2, A56
Aveberger A A94
Avouac J et al. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis, A64
Axmann R A29
Baas F A81
Babos F A2
Bader M A64
Baeten DLP A81
Baka Z et al. Immune cell-derived microparticles in polymyositis/dermatomyositis, A55
BalaguéF A140
Ballantine L A73
Bannoudi H A187
Barak V A156
Barendregt B A147
Baron M A67
Barone F A31
Barzilai O A20
Basel-Duby R A49
Baumann C A151
Baumgrass R A164
Bax M et al. Targeting Siglec-E on murine dendritic cells inhibits antigen presentation and CD4 and CD8 T cell responses, A42
Beaten D A49
Belmonte N A179
Benedetti F A61
Benelli G A161
Bennink MB A46
Bernier E A116
Bertrand J. et al. The bacterial effector protein YopM is a self-delivering immune therapeutic agent that reduces inflammation in rheumatoid arthritis, A47
Bertsias G A68
Bessis N A116
Betrand J A114
Bettelli E A180
Bianchi ME A1
Biasi D A61
Biesen R A132
Binder N A169
Blank M A20
Blom A A102
Blom AB A102
Blüml S A131
Blüml S et al. Analysis of TNFR2-mediated functions on osteoclast precursor cells, A35
Böhm C A29
Böhm C et al. ERK-activated kinase RSK2 protects against inflammatory arthritis-induced bone destruction by opposing the tumour necrosis factor α-mediated inhibition of bone formation, A24
Boileau C A162
Boissier MC A116
Bombardieri M et al. Molecular and cellular evolution of functional tertiary lymphoid structures in salivary glands of NOD mice, A12
Bombardieri S A161
Bonelli M A131
Bonelli M et al. Effects of abatacept on monocytes in patients with rheumatoid arthritis, A67
Bonnefont A-L A179
Borchardt T A55
Bos C A37
Bos WH A13
Boumans M A37
Boumpas DT A71, A177, A68, A72
Braem K et al. Involvement of chemokines in the spontaneous ankylosis mouse model: further evidence for the ‘entheseal stress’ hypothesis, A17
Brembilla NC A188
Brizzolara R A78
Broder A, Putterman C. The effects of hydroxychloroquine on antiphospholipid antibody titres in SLE, A10
Broen J et al. Skewed X-chromosomal inactivation patterns are present in systemic sclerosis and associated with FOXP3 expression, A30
Brouard S et al. Modulation of humoral immune responses as a novel mechanism of action of tumour necrosis factor blockade, A58
Bruns A A27
Bruyer A A142
Brys R A157
Buckner JH A185
Bulina I et al. Tumour necrosis factor α in rheumatoid arthritis and osteoarthritis patients in blood serum and synovial fluid, A40
Burakowski T A174
Bürgis S A48
Burmester G A8
Buttgereit F A27
Buzás E A141
Caetano-Lopes J A130
Caetano-Lopes J et al. Bone cell activity influences bone fragility and fracture risk, A20
Calmon Hamaty F et al. Lymphotoxin α stimulates proliferation and proinflammatory cytokine secretion of rheumatoid arthritis fibroblast-like synoviocytes, A61
Canete J A103
Canhão H A139, A128, A128, A130
Cantaert T A180, A81, A103, A147
Cantaert T et al. Detection of genuine anti-citrullinated protein antibodies in mice reveals their presence in BALB/c but not DBA/1 and SJL mice hyperimmunised with citrullinated collagen, A5, Elevated levels of CD5+ B cells in spondyloarthritis patients, A13
Carter S A44
Cascão R et al. Cytokine network in the first 6 weeks of rheumatoid arthritis onset, A50
Cavazzana I A22
Cazalis M-A A112
Cefle A A77
Cerezo L A141
Ceribelli A et al. Anti-argonaute 2 (Ago2/Su) and -Ro antibodies are the common autoantibody specificities in primary anti-phospholipid syndrome (PAPS), A3, Anti-Th/To antibodies in italian scleroderma patients: clinical and immunological correlations and comparison with patients with anti-centromere antibodies, A9
Cetin E A160
Chan EKL A22
Chan JYF A22
Chang H-D A164
Charbonney E A21
Charles PJ et al. Myositis associated autoantibodies detected using a novel recombinant protein blotting: clinical associations, A9
Chen W A164
Chizzolini C A188
Choi SJ A108
Chorazy-Massalska M et al. Interleukin 15 triggers differentiation/maturation of Foxp3+ T cells from bone marrow in indoleamine 2,3-dioxygenase (IDO)-dependent manner, A69
Choulaki C et al. Rheumatoid arthritis (RA) patients have variable but comparable NLRP3-inflammasome induction to controls, A36
Christianson CA et al. Persistent tactile allodynia and spinal glia activation in the K/BxN serum transfer arthritis model, A53
Churchman S A170
Cidon MJ. The script concordance test in paediatric rheumatology (SCT-PR): a novel tool to assess clinical reasoning competence, A64
Clavel C A5
Clemessy M A162
Coates L A170
Coenen MJ A75
Colato C A61
Colin EM A183
Conaghan PG A170
Cope A A8
Cornelissen F A173
Corneth OBJ A183
Corr M A135
Corrigall V A53
Corrigall VM A144
Corsiero E A31
Corvol P A162
Cosan F et al. A novel TNFRSF1 gene mutation in a turkish family: report of three cases, A31
Courties G A153
Courties G et al. A liposome-based nanocarrier for preferential targeting of the mononuclear phagocyte system in arthritic mice, A60
Creusot RJ A150
Crocker PR A106
Cromme C et al. Inflammatory tissue damage in chronic destructive arthritis is regulated by FHL2, A19
Cuthbert R A172
Cuthbert R et al. Reduced interleukin 7 serum titres are associated with progression towards rheumatoid arthritis in very early inflammatory arthritis, A68, Severity of T cell subset dysregulation influences the probability of achieving drug-induced remission in early arthritis, A67
Cutolo M A78
Cutolo M et al. Imaging and rheumatic diseases: correlation between fingertip blood perfusion and nailfold capillary impairment in systemic sclerosis, A49
Daha NA A16
Daïen C A83
Daïen CI et al. Single nucleotide polymorphism 25-TGFβ1 as a possible marker of response to rituximab in rheumatoid arthritis, A34
Daïen V A83
Dalwigk K A160
Damotte D A116
Dass S A172
de Koning M A13
de Launay D et al. Selective involvement of ERK and JNK MAP kinases in the synovial tissue of patients with early arthritis, A16, Silencing expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis, A16
De Marchis F A1
de Rijke YB A159
De Rycke L A147
De Rycke LE A103
de Steenwinkel FDO et al. Are circulating proinflammatory cytokines associated with lower birth weight of newborns from women with rheumatoid arthritis?, A63
de Vries I A115
de Vries N A81
Dechant C A165
Deelder AM A107
Dees C A64
Dees C et al. 5-HT release from platelets and activation of 5-HT2B play a crucial role for development of fibrosis in systemic sclerosis, A26, Promoter hypermethylation of the anti-fibrotic gene SOCS-3 by TGFβ as novel mechanism in the pathogenesis of SSC, A26
Del Galdo F A61
deLaunay D A168
Delavallee L A116
Deraos S A136
Derks IAM A81
Deroose C A44
Devauchelle V A35
Dietrich A A104
Dinarello CA A119
Dinser R A55
Djouad F A105
Dong J A164
Dontje W A168
Doorenspleet ME A81
Dragomir C A93
Dreier R A114
Drennan M A157
Drijfhout JW A187
Dübel S A113
Duvallet E A116
Echtermeyer F A114
Echtermeyer F et al. Syndecan-4 regulates cartilage degradation in osteoarthritis, A23
Eckes B A43
Eddleston A A155
Ekholm L A23
Elagib EM A15
el-Bannoudi H A121
Eldering E A81
Elewaut D A157
Elferink BG A187
Eliopoulos E A72
Eljaafari A et al. Mesenchymal stem cells participate in the loop leading to amplification of inflammation through secretion of interleukin (IL)6, IL1β and IL8, A70
Eloranta M-L A14
Elshafie AI et al. Comparative study between Swedish and Sudanese RA patients, A6
Ender S A43
Engelke K A29
Englbrecht M A24
Escriou V A153
Evans HG A182
Fabian A A104
Fall PB A179
Fang Z A164
Fardellone P A170
Fatini C A161
Faustino A A139
Faustova M et al. Genetic variation in promoter sequence of B cell-activating factor gene is associated with increased risk of myositis development, A31
Feitsma AL et al. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4 positive RA patients, A74
Feldt O A129
Ferner E A131
Ferrari-Lacraz S et al. Upon contact with stimulated T cells, expression of peptidylarginine deiminase 2 and 4 is upregulated in human monocytes, A2
Ferrone C A124
Fiehn C A55
Finckh A A140
Firestein GS A135
Fischer S A137
Floessdorf M A164
Fluiter K A123
Fonseca JE A139, A128, A128, A130
Foulquier C A4
Foussat A A179
Franceschini F A22
Franco Salinas G A147
Franco Salinas G et al. Constitutive co-stimulation by B cells is sufficient to trigger T cell-driven autoimmune disease, A71
Franek BS A80
Frank S et al. Upregulated SUMO-2/3 expression is involved in the regulation of apoptosis and matrix metalloproteinase expression in rheumatoid arthritis synovial fibroblasts, A30
Franken KLMC A187
Frey B A42
Frommer K et al. Potential adipokine involvement in systemic sclerosis, A25
Fuhrmann F A164
Füst G A3
Gabay C see Genevay S et al, see Lamacchia C et al
Gabba S A31
Gallo F A78
Gansler J A137
Garaud S A34
Garcia-Vallejo JJ A106
Garrison Fathman C A150
Gasc JM A162
Géher P A3
Genevay S et al. Adalimumab in severe and acute sciatica, A55
Georg Schett A64
Gerlag DM A37
Gershwin ME A20
Gessner A A48
Geurts-van Bon L A75
Geyer M et al. Joint regeneration in newts? Yes, they can!, A22
Giacomelli R A161
Gilchrist D A101
Goëb V A170
Gottschal L A81
Goulielmos G A89
Goulielmos GN A72
Goulielmos GN et al. The CD40 region is associated with multiple autoimmune diseases in the greek population, A29
Grabiec AM A168
Gracie A A101
Gracie JA A73
Graef D A24
Grevers L A102
Grevers LC A54
Grevers LC et al. Immune complex-mediated inhibition of osteoclastogenesis: role for the inhibitory FC γ receptor IIB in bone erosion in antigen-induced arthritis?, A23
Grigoriadis A A53
Grouard-Vogel G A116
Grün JR A79
Grunke M A165
Guerrier T A105
Gul A A77
Gullick NJ et al. Interleukin 17-producing cells are increased in the peripheral blood of patients with rheumatoid arthritis and are enriched at the site of inflammation, A72
Günther A A62
Gusinde J A64
György B et al. Natural autoantibodies reactive to glycosaminoglycans are disease state markers in rheumatoid arthritis and are associated with HLA, A2
Haftmann C A164
Hamann D A13
Hamann J A123
Haslbeck M A24
Hayer S et al. Interleukin-6 is not a crucial regulator in tumour necrosis factor-mediated bilateral sacroiliitis, A49
Hegazy A A164
Heinhuis B et al. IL-32γ and streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2, A47
Heinz G A164
Hendriks RW A173
Hensor E A172
Herenius MM A81
Herman S A151
Herman S et al. Apoptosis and the subsequent generation of autoantigens as initial triggers in the pathogenesis of experimental autoimmune arthritis, A60
Hermann K-G A27
Hermann S A48
Herrmann M A1
Herzog C A114
Hess A A29
Heyder P A1
Hilkens CMU A184
Hillion S et al. Intravenous immunoglobulin promotes apoptosis of mature human B lymphocytes by using CD22 to modulate their antigen B cell receptor, A48
Hillmann A A48
Hoek RM et al. Deletion of either CD55 or CD97 ameliorates arthritis, A48
Höfer T A164
Hoffmann M A151
Hoffmann M et al. Heterogeneous nuclear ribonucleoprotein-associated nucleic acids trigger disease in a rat transfer model of arthritis, A40
Hofkens W et al. Systemically delivered glucocorticoid liposomes suppress bone erosion and inhibit osteoclast activation in synovium and bone marrow during experimental murine arthritis, A21
Hokken ACS A159
Horn A A64
Horn A et al. Activation of Hedgehog signalling plays a crucial role in the pathogenesis of systemic sclerosis, A27
Horner EA A170
Hot A et al. Pathogenic role of IL-17 in endothelial dysfunction, a link between rheumatoid arthritis and atherosclerosis, A44
Houwing-Duistermaat JJ A16
Hoyer BF et al. Takayasu's arteritis characterised by disturbances of B cell homeostasis responds to B cell depletion with RITUXIMAB, A11
Hudecz F A2
Hudson M A67
Hueber A A73
Hueber AJ A101
Hueber AJ et al. Alarmin interleukin 33 is overexpressed in psoriasis and induces ST2-dependent psoriasis-like dermatitis, A40
Hügle T et al. Analysis of mononuclear cell subsets in dermis and blood of patients with systemic sclerosis by multicolour flow cytometry, A25
Huijbens R A95
Huijbens RJF A98
Huizinga TWJ A187, A121, A16, A16
Hulejova H A76
Humrich J et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus, A43
Humrich JY A109
Hunter J A73
Ibba-Manneschi L A161
Ibba-Manneschi L et al. Histopathological modifications in haemophilic synovial tissue, A64
Innocenti M A161
Ioan-Facsinay A A187, A16, A121
Ioan-Facsinay A et al. Anti-CCP antibodies are a collection of ACPA that are cross-reactive to multiple citrullinated antigens, A8
Ioannou M et al. Plasmacytoid dendritic cells regulate the magnitude of an autoimmune response through expansion of suppressive monocytes, A54
Isaacs JD A184
Jacques P A157
Jahn A A164
Jakobs ME A81
Jakobsson P-J A10
James R A21
Jamin C et al. Anti-ATP synthase autoantibodies alter endothelial cell (EC) survival by disrupting PH regulation in vasculit, A10, Toll-like receptor 9 (TLR9) controls B cell differentiation in salivary glands of patients with Sjögren's syndrome, A42, Toll-like receptor 9 (TLR9) controls B-cell differentiation in salivary glands (SG) of patients with Sjögren's syndrome (SS), A7
Jastrzebska M A174
Jastrzebska M et al. Rheumatoid adipose tissue is a potent source of cytokines, A53
Jaunalksne I A100
Jayaraj D A182
Ji JD et al. Regulation of interleukin-1β expression by 1,25-dihydroxyvitamin D3 in human macrophages, A43
Jolly M A80
Jol-van der Zijde CM A16
Joosten L A42
Joosten LAB A119
Jorgensen C A153, A83, A83, A179, A105, A153
Jourdin-Boucard M A179
Jovanonic V A147
Jun J-B A108
Jünge A A64
Kahan A A162
Kalden JR A1
Kardassis D A72
Kariuki SN A80
Karonitsch T et al. IFN-gamma promotes fibroblast-like synoviocytes motility, A63
Karpus O A123
Katz B-SP A20
Kaur Singh S A106
Kavousanaki M et al. Interleukin 21-conditioned dendritic cells promote T cell reactivity through the downregulation of ICOS-L, A70
Keitzer R A27
Kerzendorf U A165
Khalafalla KE A15
Kiener HP A160
Kim AHJ et al. A novel model of murine B cell-mediated proteinuria identical to human minimal change disease, A15
Kim S-H A119
Kim T-H A108
Kim Y A108
Kireva T et al. Proteasome inhibition aggravates tumour necrosis factor-mediated bone resorption, A16
Kirkham BW A182
Kirou KA A37
Kirschning C A1
Kittel Á A141
Kivity S et al. Thyroid disease and vitamin D deficiency, A62
Klarenbeek PL et al. Complete T and B cell receptor repertoire analysis in rheumatoid arthritis using high throughput sequencing, A33, High throughput sequencing (HTS) provides full repertoire analysis of the B and T cell receptors in humans and mice, both in blood and synovial tissue, A33
Klavinskis LS A144
Klevenvall L A94
Klich K A185
Kloke L A109
Kloppenburg M A121
Kny A A151
Koenders M A42
Koenders MI A119
Koenders MI et al. IL-21R deficiency during experimental arthritis increases local expression of inflammatory mediators but protects against joint pathology by suppressing Th17 cells, A73
Kollias G A29, A49, A48, A43, A114, A43
Koncz A A3
Konthur Z A8
Kop EN A123
Korb A et al. The TRAF6 binding molecule p62/SQSTM1 is a critical regulator of inflammatory bone destruction, A19
Kotsakis S A7
Kovalchuk L A100
Krasoudaki E A68
Krausz S et al. Macrophage stimulation by angiopoietins-1 and -2 promotes recruitment and retention of white blood cells at sites of inflammation, A37
Krönke G A91
Krystufkova O A76
Kuchroo VK A180
Kurowska-Stolarska M et al. miR-155 and miR-34a regulate proinflammatory cytokine production by human monocytes, A30
Kyriakidis NC A7
Lafyatis R A75
Lamacchia C et al. Production and biological role of hepatocyte and myeloid cell-derived interleukin-1 receptor antagonist in a model of systemic inflammation, A58
Lang V et al. The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib, A12
Langerak AW A75
langevitz P A156
Larida B A20
Laurent L et al. Rheumatoid factor amplifies the macrophage secretion of TNFα induced by ACPA-citrullinated fibrinogen immune complexes, A2
Lavrentjevs V A100
Le Blay P et al. Genetic markers in clinical subtype of juvenile idiopathic arthritis, A34
Le Dantec C A34
Le Loët X A170
Le Pottier L A105
Le Pottier L et al. B cell activating factor of the TNF family: δ4BAFF, an alternate-splice isoform that acts as a transcription factor and exaggerates its production in autoimmunity and cancer, A14
Lee B A108
Lee YH A108
Lee YJ A114
Leenen PJM A54
Lefèvre S A137
Lefèvre S et al. Migrating synovial fibroblasts: a homogenous population?, A54
Leipe J et al. Th17 cells in autoimmune arthritis, A69
Lems WF A30
Lenief V A112
Li N A164
Lin F A123
Linari S A161
Lindemann O et al. Transient receptor potential (TRP) channels contribute to neutrophil chemotaxis during the inflammatory response, A41
Lindroos E A133
Lipsky PE A176
Litjens M A106
Loddenkemper K A27
Loell I A133
Loell I et al. Effects of immunosuppressive treatment on leukotriene pathway in polymyositis and dermatomyositis, A62
Löhning M A164
Loiler SA A115
Lopes A A139
Lora M A121
Lories RJ A44
Louis-Plence P A179
Ludwig C A83
Lukitsch I A109
Lund O A181
Luyten FP A44
Mach F A21
Magyar A A2
Mally S A104
Manetti M A161
Manetti M et al. Association between the MMP-12 gene and systemic sclerosis: role of RS2276109 functional polymorphism in the modulation of skin and pulmonary fibrosis, A35
Manfredi AA A1
Mann H A141
Mantello A A179
Marenzana M et al. Differential distribution of a PEGylated Fab' into inflamed versus normal tissue compared with an IgG in arthritis and colitis models, A61
Marijnissen RJ A119
Marijt KA A121
Marklein B et al. JKTBP (HNRNPDL) is a novel TOLL7/9 dependent target in humans and animal models of inflammatory rheumatic diseases, A4, Toll-like receptor (TLR-7/9), MyoD88, Tir8, dependent and independent autoantigens, A39
Martin Jäck H A29
Martire D et al. Single injection of antigen-specific regulatory Tr1 lymphocytes protects mice from severe collagen-induced arthritis, A71
Marzo-Ortega H A170
Masdar H A103
Mashreghi M-F A164
Matsoukas J A136
Matthes T A188
Matucci-Cerini M A20
Maza S A27
McGowan N A53
Mcinnes I A42
McInnes IB A101, A101, A73, A133
McKenzie EJ A106
Medof ME A123
Meinecke I A114
Melchiorre D A161
Melissourgaki M A71
Ménard HA A121
Meyer LH A49
Mikolaitis RA A80
Millar NL A101
Mingozzi F A115
Misják P A3
Mittoo S et al. Predicting lung function decline in systemic sclerosis (SSc), A27
Modesti M A149
Moizant F A147
Molinari N A83
Montagna P A78
Montecucco C A161
Monteiro J A139
Morfini M A161
Moura R A130
Moura RA A128
Moura RA et al. Cytokine profile in serum and synovial fluid of patients with established rheumatoid arthritis, A51
Müler-Ladner U A137
Mullazehi M et al. Anti-type ii collagen-immune complex-induced production of interleukin 1β and tumour necrosis factor α stimulate production of matrix metalloproteinases from monocyte/rheumatoid arthritis synovial fibroblast co-cultures, A51
Müller C A55
Müller-Ladner U A62, A55, A150, A137
Müller-Schrobsdorff F A55
Mumtaz IM A27
Munoz L A1
Mus AMC A183
Mus AMC et al. Interleukin (IL)23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for IL22 but not IL21 in autoimmune experimental arthritis, A69
Nader G A133
Nagelreiter I A126
Nakou M A68
Nam J A170
Näther M A109
Neregård P A58
Nesbitt A A155
Neumann E A62, A137, A150, A137
Newsom-Davis T A171
Nickerson-Nutter C A119
Nicola B A20
Niedereiter B A160
Niedermeier M A104
Niederreiter B A169, A49, A126, A131
Niewold TB A80
Nimmerjahn F A113
Nkoulou R A21
Noel D A105
Nolte M A180
Noordenbos T et al. Mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis, A41
Noort A-R et al. Nuclear factor-κB (NF-κB) inducing kinase is preferentially expressed in rheumatoid arthritis synovial tissue containing ectopic lymphoid neogenesis, A59, Nuclear factor-kappa B (NF-kappaB) inducing kinase is preferentially expressed in rheumatoid arthritis synovial tissue containing ectopic lymphoid neogenesis, A60
Norein SA A15
Novota P A76
Nowak B A127
Nur MAM A15
Nurmohamed MT A30
Oerum H A123
Oliveira ASF A110
Oliver Distler HW A64
Orphanos N A177
Ossipova E et al. Identification of specific citrullination sites on fibrinogen in RA, A4
Ottosson C A133
Pagano S A21
Palmer G A148
Palotai R A181
Palumbo K A64
Panayi G A53
Panayi GS A144
Pap T A104, A49, A114, A43, A48, A104, A43, A114, A43, A114, A114
Papadopoulos G A71
Papendieck A A109
Paramarta JE A103
Pasquali J-L A5
Pásztói M A3
Patakas A A42
Paterson E A23
Paul Emery A61
Pauley BA A22
Pavenstädt H A48
Pawlak D A174
Pena A A139
Pennings B A98
Pereira da Silva JA A166
Perpétuo IP A139
Perpétuo I A128
Perpétuo I et al. Influence of anti-tumour necrosis factor drugs, tocilizumab and methotrexate on osteoclast differentiation, A20, Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate, A55
Pers J A105
Pers J-O A120, A105, A105, A34, A35
Pers Y-M A153
Pers YM et al. The microRNAs as biomarkers in knee osteoarthritis, A48
Peter Tak P A147
Peters MA et al. Loss of integrin α2β1 reduces tumour necrosis factor-dependent inflammatory cartilage destruction and matrix metalloproteinase expression through modulating extracellular signal-regulated kinase, A22
Petríková J et al. Prevalence of Toxoplasma antibodies among patients with various autoimmune diseases, A8
Philippe A A109
Pitzalis C A31
Pizzorni C A124
Plant D A71
Pohle S A113
Polgár A A3
Polido-Pereira J A128, A128, A130
Polzer K A42
Polzer K et al. Anti-interleukin 17A therapy inhibits tumour necrosis factor-mediated bone loss by modulation of T cell balance, A18
Ponikowska M A127
Pozsonyi E A3
Pratt AG et al. Peripheral blood CD4 T cell gene expression profiles as predictive biomarkers in early arthritis, A72
Presumey J A153
Presumey J et al. Negative regulation of BIK by the micro RNA-125b interferes with macrophage apoptosis in rheumatoid arthritis, A35
Proctor G A31
Prots I A189
Prots I et al. Molecular mechanisms of peripheral CD25 regulatory T cell (Treg) development, A70
Pruijn GJM A13
Purath U et al. Adoptive cellular gene therapy of autoimmune arthritis using a combination of lentivirally transduced dendritic cells, A59
Putova I A23
Putterman C A26
Queiroz MV A128
Radbruch A A132, A27, A79, A125, A164
Radtke H A132
Radzikowska A A174
Rajewsky N A164
Ram M A20
Ramirez J-M et al. Activation of the aryl hydrocarbon receptor in vivo primes human T cells for interleukin 22 production and inhibits Th17 cells, A74
Ramming A A189
Ramos MI et al. Fms-like tyrosine kinase 3 ligand (Flt3L) levels are elevated in RA synovial fluid, A43
Raposo BR et al. Disease amelioration in the K/BxN mouse model of spontaneous chronic arthritis after CD8 T cell depletion, A66
Raterman HG A30
Rath E A131
Rath E et al. Analysis of polymorphonuclear neutrophil (PMN) phenotype and function at the onset of collagen-induced arthritis, A51
Ratsimandresy R A116
Ravera F A124
Rawstron A A172
Reber G A21
Reedquist KA A168, A123, A123, A168, A41
Reindl C A165
Remans P A147
Renaudineau Y et al. Endogenous retrovirus control is impaired in B cells from patients with systemic lupus erythematosus, A34, NFAT2 and STAT3 control type 2 cytokines in CD5 B cells, A14
Revu S et al. Methothrexate directly inhibits RANKL expression and osteoclast formation in very early arthritis, A23
Rhee L A80
Richardson S A184
Rieck M A185
Riemekasten G et al. Systemic sclerosis as prototypic disease with high levels of functional antibodies against angiotensin II type-1 and endothelin-1 type A receptor strongly predicting prognosis, A5
Rittore C A83
Riveiro-Naveira R A143
Riveiro-Naveira RR A143
Robinson D A67
Rodière M A83
Rodriguez E A148
Roeb E A62
Rojkovich B A3
Romano E A161
Rönnblom L A14
Roosnek E A188
Rose T A132
Rossier MF A21
Roth B et al. Cellular Factor XIII and peptidylarginine deiminase-catalysed citrullination in rheumatoid arthritis, A4
Rouquier S A179
Routsias JG et al. Structural insights into antigenicity of Ro/La ribonucleoprotein: SLE related epitopes are cryptic, masked by hY1 RNA, A3
Roux-Lombard P A21
Rovere-Querini P A1
Rudnicka W A174
Ruiz B A162
Rüther C A104
Saeland E A106
Salinas GF et al. TNFα blockade impairs T cell dependent humoural responses, A13
Salloum R et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon α activity in patients with systemic lupus erythematosus, A32
Saraux A A105
Sármay G A2
Satoh M A22
Sattar N A101
Sattler A A132
Saurat J-H A188
Scanzello CR A93
Schäfers M A48
Scharnert J A104
Scharstuhl A A98
Scheinecker C A131, A160, A131
Schelbergen R A102
Schelbergen RFP et al. Alarmins S100A8 and S100A9 skew chondrocytes towards a cartilage breakdown phenotype, A44
Scherman D A153
Schett G A29, A42, A29, A42, A91, A113, A1, A24, A53
Schierbeck H A94
Schierbeck H et al. Immunomodulatory drugs can inhibit the extracellular release of HMGB1 from cultured human monocytes, A36
Schmeiser T A62
Schmidt A A104
Schnaeker EM A49
Scholtysek C et al. NR4A1 modulates the inflammatory response during murine experimental arthritis, A37
Schramm M et al. Elevated expression of the Th17 cytokine interleukin 22 in rheumatoid arthritis, A65
Schreiyäck C A55
Schreurs M A30
Schubert K A129
Schulze-Koops H A165, A176, A165, A189
Schwab A A104
Scott JL et al. Complement activation and regulation in early and advanced stage osteoarthritis, A37
Screaton GR A171
Sebestyén Simon P A141
Seeuws S et al. A multiparameter approach to monitor disease activity in collagen-induced arthritis, A62
Sehnert B A24
Sehnert B et al. A Tissue-specific NF-κB inhibitor ameliorates inflammatory joint diseases, A45
SéitéJ-F A120
Selmi C A20
Semerano L A116
Sengler C A27
Senolt L A141
Senolt L et al. Metastasis-promoting protein S100A4 (MTS1) upregulates production of proinflammatory cytokines via TLR-4, A38
Shapira Y A20
Shapira Y A156
Shaw AS A108
Shields AM et al. Treatment of collagen-induced arthritis with lentiviral BiP improves clinical parameters of disease, A56
Shlomchik M A8
Sidiropoulos P A71
Sieper J A125
Sigridur Hreggvidsdottir H et al. Interleukin 1β and TLR ligands give enhanced cytokine production by their interaction with HMGB1, A38
Sikora E A100
Skapenko A A165, A176, A165, A189
S-Koops H A189
Skriner K A8
Sloetjes AW A102
Slowinski T A109
Smiljanovic B et al. Defining TNFα-, IFNα- and IFNγ-induced gene expression profiles in human monocytes to estimate their cytokine-specific impact in inflammatory diseases, A32
Snir O et al. Identification and function of T cells reactive with citrullinated vimentin in HLA-DRB1*0401 humanised mice and rheumatoid arthritis patients, A73
Sochnev A A100
Sohn J A108
Sokolik R et al. Early diagnostic Achilles tendinopathy in patients with psoriasis and arthralgia, A50
Soldano S et al. Modulation of gene expression by leflunomide and prednisone during treatment of early rheumatoid arthritis, A31
Soler S A83
Song GG A108
Song YW A114
Sorg O A188
Soulillou J-P A147
Souto-Carneiro MM A128, A128, A166
Stagakis E et al. Micro RNA analysis reveals novel genes in human systemic lupus erythematosus: miR-21 affects PDCD4 expression and regulates aberrant T cell responses, A28
Steinbrich-Zöllner M et al. Ankylosing spondylitis: immunophenotypical characteristics of peripheral blood and synovial fluid compartments, A49
Steiner CW A151
Steiner C-W A131
Stenberg P A102
Stittrich A-B et al. MicroRNA-182 promotes clonal expansion of activated T helper cells, A65
Stoianovic-Susulic V A121
Stolarski B A73
Storm G A54
Stratis A A114
Stratis A et al. Antibodies against syndecan-4 reduce cartilage destruction in RA-like disease of hTNF transgenic mice, A45
Strietholt S et al. SUMO-specific protease 7 (SENP7) regulates matrix metalloproteinase-9 expression in synovial fibroblasts, A17
Su L Profiling the T cell repertoire in rheumatoid arthritis, A75
Sulli A A124
Superti-Furga G A169
Suwannalai P et al. Anti-citrullinated protein antibodies have a low avidity compared to antibodies against recall-antigens, A7
Svensson CI A135
Swan DC A184
Szabó TG et al. Critical role of protein glycosylation in T cell immunity/autoimmunity, A71
Szarka E et al. Identification of a new citrullinated epitope on filaggrin for the early diagnosis of rheumatoid arthritis, A1
Szekanecz Z A156
Szyper-Kravitz M A156
Taams LS A182
Tak PP A115, A168, A103, A123, A180, A123, A81, A168, A103, A149, A110, A37, A41, A171, A103
Tak P-P A147
Talabot-Ayer D A148
Tarner IH A150
Tartelin M-L A178
Tas SW A149
Teitsma C A103
Teitsma CA A103
Tekstra J A37
Thiel A A132
Thompson SJ A144
Thümmler K et al. Immune regulation by peripheral Tregs induced upon homotypic T cell/T cell interactions, A74, Immune regulation by peripheral Tregs induced upon homotypic T cell/T cell interactions, A75
Thurlings RM et al. The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis, A14
Tiersma Y A103
Tinazzi I et al. Differential pattern of expression of caveolin-1 and AIF-1 in chronic graft-versus-host disease suggests a specific role in the pathogenesis of systemic sclerosis, A24
Tincani A A22
Tobón GJ A105
Tobón GJ et al. Sjögren's syndrome (SS): are increased serum levels of cytokine FMS-like tyrosine kinase 3 ligand (Flt3L) indicative of lymphoma?, A14
Toes REM A187, A121, A16, A16, A121
Tokatly I A181
Tony Holden M A63
Toussa S A71
Tzioufas AG A7
Uderhardt S A91
Ujfalussy I A3
Umlauf D A104
Undeutsch R A109
Undeutsch R et al. Interleukin10-producing CD4 T cells ameliorate murine lupus in NZB/W F1 mice, A66
Unger W A106
Urbonaviciute V et al. HMGB1 containing nucleosomes from apoptotic cells induce inflammation and immune activation via TLR2 – implications for the etiopathogenesis of systemic lupus erythematosus, A1
Utset TO A80
Vaamonde-García C A143
Vaamonde-García C et al. Inflammatory response is modulated by mitochondrial dysfunction in cultured normal human chondrocytes, A15
Vacher-Lavenu MC A162
Valcárcel-Ares MN et al. A novel role for mitochondrial dysfunction in the inflammatory response of rheumatoid arthritis, A56
Valcarcel-Ares N A143
Vale M A139
Valeria Riccieri A62
van Baarsen LG A37
van Bon L A95
van Bon L et al. Modulating TLR responses in systemic sclerosis via heme oxygenase-1, A39
van de Burg M A147
van de Geijn FE et al. Can mannose-binding lectin explain the course and outcome of pregnancy in rheumatoid arthritis?, A42
van de Loo FA A119
van de Loo FAJ A46
van de Sande M A103
van de Sande MGH A123
van de Sande MGH et al. The Ang-1/Tie2 angiogenic axis is selectively engaged in rheumatoid arthritis (RA) synovial tissue even before ACR criteria of RA are met, A28, Expression of Tie2 and Ang-1 is related to the development of persistent and erosive disease in patients with early arthritis, A28
van de Stadt LA et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in seropositive arthralgia patients, A6
van de Stadt RJ A13
van den Berg WB A46, A102, A119, A54, A119, A102, A102, A95
van der Horst A A13
van der Kraan PM A46
van der Pouw Kraan T A30
van der Voort EIH A187
van der Woude D et al. A gene–environment interaction between HLA SE alleles and smoking affects the reactivity of ACPA to various citrullinated antigens, A7
van Hamburg JP A173
van Hamburg JP et al. CCR6 Th17 but not CCR6 Th1 cells cooperate with synovial fibroblasts in a proinflammatory feedback loop in early rheumatoid arthritis, A72
van Kampen AHC A81
van Kooyk Y A106
van Lent PL A54
van Lent PLEM A102, A119, A102
van Lent PLEM et al. Alarmin S100A8 causes severe cartilage damage in antigen-induced arthritis through TLR4 activation and upregulation of FcɛRI and FcɛRIV, A41
Van Lier RA A180
van Maanen MA A123
van Osch GJVM A121
Van Praet J A157
van Riel PLCM A95
van Schaardenburg D A13
van Schaik BDC A81
van Tol MJ A16
van Vliet SJ A106
van Westing DM A37
van Zoest KPM A149
Vandeghinste N A157
Vasile M A62
Vassou D et al. Role of the pro-apoptotic pyrin-interacting protein Siva in the pathogenesis of familial mediterranean fever, A29
Vaz MF A139
Vazgiourakis V A71
Vencovský J A141
Venetia Bigley A63
Verbeek JS A123
Verduyn W A16
Vervoordeldonk MJ A115, A168, A123
Verweij C A30
Verweij CL A37
Vestweber D A113
Viatte S A140
Vieira PL et al. Expansions of interleukin 21-secreting CD4 T helper cells in inflammatory arthritides, A68
Villaggio B A78
Villeneuve E A170
Vital E A170
Vital EM et al. High serum B cell activating factor predicts good clinical response to rituximab in RA: pilot data, A11
Vittecoq O A170
Volgers C A95
Voll R A113
Vonk M A98
Vonk MC A75
Vos K A37
Voskuyl A A30
Vosslamber S et al. IFN signature determines responder status on B cell depletion in rheumatoid arthritis patients, A12
Vreijling J A123
Vugler A A155
Vuilleumier N et al. Anti-apolipoprotein A-1 autoantibodies as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction, A8
Wagener F A98
Wagner H A1
Walgreen B A54
Wanivenhaus A A160
Warnawin E A174
Weber CK et al. Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP AND Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus, A10
Weenk M A95
Wehmeyer C A114
Wehmeyer C et al. The role of the Wnt inhibitor sclerostin in rheumatoid arthritis, A21
Weide T A48
Wenink MH A98
Wenink MH et al. β2 Integrins control the proinflammatory phenotype of type 1 macrophages and dendritic cells, A38
Wensveen FM A81
Wessels J A113
Wietelmann A A55
Wiland P A127
Will C A49
Willemsen SP A107
Wilson G A184
Wipff J A162
Wixler V A49
Wolbink GJ A13
Wollheim F A102
Wolvers-Tettero ILM A75
Woo JH A108
Wooley PH A144
Wu P A125
Wuhrer M A107
Wunrau C et al. Induction of death receptor ligand-independent apoptosis by endogeneous TIMP3 in mesenchymal cells, A18
Yaksh TL A135
Yazici A A77
Yeremenko N A103
Yeremenko N et al. Decreased soluble tumour necrosis factor expression in spondylarthritis versus rheumatoid arthritis synovitis, A57
Yilmaz-Elis AS A123
Yoo D-H A108
Youinou P A120, A105, A105, A34, A35
Young DA A184
Yusuf E et al. Immunological characterisation of Hoffa's fat pad in osteoarthritis, A48
Zagury D A116
Zagury JF A116
Zaiss M et al. Regulation of osteoclast differentiation and function by BiP, A21
Zaiss MM A29
Zampogna G A124
Zepa J A100
Zervou M A71
Zimmermann B A137
Zimmermann B et al. Migratory potential and influence on neoangiogenesis of rheumatoid arthritis synovial fibroblasts, A57
Zisappl M A156
Zwerina J A64
Zong M et al. Effect of immunosuppressive treatment on interleukin 15 in muscle tissue of patients, A52
Zubarev R A10
Zufferey P A140
Zuurmond A A121